CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Adding immunotherapy to chemotherapy improves survival for endometrial cancer patients68090
Issue Information12415
Erratum to “An update on the immune landscape in lung and head and neck cancers”9462
Issue Information2815
Cancer statistics, 20252279
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer1480
Sustained weight loss may reduce cancer risk1176
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer1158
994
Minority groups underrepresented in hematologic cancer trials560
Cancer risk among World Trade Center rescue and recovery workers: A review387
Genomic‐derived radiation dosage improves prediction of outcomes350
Study identifies signs and symptoms of colorectal cancer risk at younger ages344
Childhood cancer survivors face greater risks of subsequent malignant neoplasms from human papillomavirus274
Breast cancer survivors face greater cardiometabolic risks237
To lower cancer risks, study shows that food choices matter212
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey211
Issue Information204
New studies examine COVID‐19 risks among cancer patients189
Critical care management of chimeric antigen receptor T‐cell therapy recipients176
167
Issue Information150
Most young female cancer survivors are at minimal risk for obstetric problems108
An overview of real‐world data sources for oncology and considerations for research107
Clinical management of metastatic colorectal cancer in the era of precision medicine105
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019103
Cancer treatment and survivorship statistics, 202294
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies87
Cancer statistics, 202485
Cancer care for people with dementia: Literature overview and recommendations for practice and research79
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates76
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions72
American Cancer Society nutrition and physical activity guideline for cancer survivors71
American Cancer Society's report on the status of cancer disparities in the United States, 202168
Cancer statistics for the US Hispanic/Latino population, 202167
Screening for lung cancer: 2023 guideline update from the American Cancer Society65
Prevention of device‐related infections in patients with cancer: Current practice and future horizons61
Virtual exercise regimens can help patients with cancer60
Locally advanced lung cancer53
Becoming the new editor for CA: The future is now51
Tumor board presentation of a woman with metastatic, hormone receptor‐positive, mismatch repair‐deficient endometrial cancer47
How can hospitals change practice to better implement smoking cessation interventions? A systematic review44
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review43
39
Near majority of adults favor R ratings for films with smoking39
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries36
Issue Information35
Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work35
Routine Cancer Screening Rates Rebound After Deep Drop From Pandemic Fear33
Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review30
Issue Information26
Issue Information25
Team approach for nonmedical opioid use24
Issue Information23
22
Multidisciplinary approach for a high‐risk, localized soft tissue sarcoma of the trunk after unplanned nononcological resection21
Better communication is key for quality‐of‐life improvement in low‐income and minority patients21
Skipping breakfast is a bad idea for patients with cancer20
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer20
20
Novel clinical trial designs emerging from the molecular reclassification of cancer19
17
Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival16
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians15
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians14
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors14
Modern developments in germline pharmacogenomics for oncology prescribing14
13
12
12
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer11
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies10
10
Pairing smoking cessation with lung cancer screening may save lives10
Cervical cancer prevention and control in women living with human immunodeficiency virus10
Cancer misinformation on social media10
It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 19
Cancer statistics 2024: All hands on deck9
Issue Information9
Integrative oncology: Addressing the global challenges of cancer prevention and treatment9
9
Multicancer detection tests: What we know and what we don’t know8
Better solutions needed to reduce suicides among patients with cancer8
Cancer diagnosis and treatment in working‐age adults: Implications for employment, health insurance coverage, and financial hardship in the United States7
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy7
COVID concerns highlight the importance of adequate fecal immunochemical test sample collection7
Reviewer acknowledgement 20217
Issue Information6
Colonoscopies for patients aged 45–49 years yield positive results6
Both leading molecular thyroid tests may reduce the need for diagnostic surgery5
Issue Information5
Recent progress in the treatment of cancer in children5
Reviewer acknowledgement 20235
4
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice4
Fecal microbiota transplants may aid melanoma immunotherapy resistance4
Cancer epigenetics in clinical practice4
4
Virtual Tumor Board: Papillary thyroid carcinoma with nodal disease4
Opportunistic salpingectomy may reduce ovarian cancer risk4
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review4
Key issues face AI deployment in cancer care4
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward3
Most patients with cancer are not undergoing germline genetic testing3
Cancer statistics, 20223
Opioid analgesics for nociceptive cancer pain: A comprehensive review3
Reviewer acknowledgement 20242
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies2
Immunosurveillance in clinical cancer management2
Erratum to “Cancer statistics, 2024”2
Nutrition and Physical Activity Guideline for Cancer Survivors2
Current treatment and future directions in the management of anal cancer2
Social determinants of health and US cancer screening interventions: A systematic review2
0.082074165344238